NMPA Approval

Levocetirizine Dihydrochloride Oral Drops

Approval Number

国药准字H20237062

Company广州一品红制药有限公司

Registration Date

June 7, 2023

Previous Approval Numbers

国药准字H20213385

Drug Information

Generic Name

盐酸左西替利嗪口服滴剂

Dosage Form

口服溶液剂

Strength

15ml:75mg

Drug Type

化学药品

Registration Date

June 7, 2023

Company Information

Applicant Company

Company Name广州一品红制药有限公司

Company Address

广州市经济技术开发区东区东博路6号

Manufacturing Company

Company Name广州一品红制药有限公司

Company Address

广州市经济技术开发区东区东博路6号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

盐酸左西替利嗪口服滴剂 - NMPA 批准文号 | MedPath